...
首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions.
【24h】

Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions.

机译:肺表面活性剂膜和膜的结构:蛋白质和脂蛋白相互作用的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The pulmonary surfactant system constitutes an excellent example of how dynamic membrane polymorphism governs some biological functions through specific lipid-lipid, lipid-protein and protein-protein interactions assembled in highly differentiated cells. Lipid-protein surfactant complexes are assembled in alveolar pneumocytes in the form of tightly packed membranes, which are stored in specialized organelles called lamellar bodies (LB). Upon secretion of LBs, surfactant develops a membrane-based network that covers rapidly and efficiently the whole respiratory surface. This membrane-based surface layer is organized in a way that permits efficient gas exchange while optimizing the encounter of many different molecules and cells at the epithelial surface, in a cross-talk essential to keep the whole organism safe from potential pathogenic invaders. The present review summarizes what is known about the structure of the different forms of surfactant, with special emphasis on current models of the molecular organization of surfactant membrane components. The architecture and the behaviour shown by surfactant structures in vivo are interpreted, to some extent, from the interactions and the properties exhibited by different surfactant models as they have been studied in vitro, particularly addressing the possible role played by surfactant proteins. However, the limitations in structural complexity and biophysical performance of surfactant preparations reconstituted in vitro will be highlighted in particular, to allow for a proper evaluation of the significance of the experimental model systems used so far to study structure-function relationships in surfactant, and to define future challenges in the design and production of more efficient clinical surfactants.
机译:肺表面活性剂系统构成了一个很好的例子,说明动态膜多态性如何通过在高度分化的细胞中组装的特定脂质-脂质,脂质-蛋白质和蛋白质-蛋白质相互作用来控制某些生物学功能。脂蛋白表面活性剂复合物以紧密堆积的膜的形式组装在肺泡肺细胞中,并被储存在称为片状体(LB)的特殊细胞器中。 LB分泌后,表面活性剂会形成一种基于膜的网络,可快速有效地覆盖整个呼吸表面。这种基于膜的表面层的组织方式允许进行有效的气体交换,同时优化上皮表面上许多不同分子和细胞的相遇,这是确保整个生物体免受潜在病原体入侵者侵扰的重要手段。本综述总结了关于不同形式的表面活性剂的结构的已知知识,特别强调了表面活性剂膜组分的分子组织的当前模型。表面活性剂结构在体内显示的结构和行为在一定程度上由体外研究不同表面活性剂模型所表现出的相互作用和特性来解释,特别是解决了表面活性剂蛋白可能发挥的作用。但是,将特别强调在体外重构的表面活性剂制剂的结构复杂性和生物物理性能方面的局限性,以便对目前用于研究表面活性剂中的结构-功能关系的实验模型系统的重要性进行适当的评估,并在设计和生产更有效的临床表面活性剂方面定义了未来的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号